Literature DB >> 33524049

Aberrant binding of mutant HSP47 affects posttranslational modification of type I collagen and leads to osteogenesis imperfecta.

Delfien Syx1, Yoshihiro Ishikawa2,3, Jan Gebauer4, Sergei P Boudko2, Brecht Guillemyn1, Tim Van Damme1, Sanne D'hondt1, Sofie Symoens1, Sheela Nampoothiri5, Douglas B Gould3,6, Ulrich Baumann4, Hans Peter Bächinger2, Fransiska Malfait1.   

Abstract

Heat shock protein 47 (HSP47), encoded by the SERPINH1 gene, is a molecular chaperone essential for correct folding of collagens. We report a homozygous p.(R222S) substitution in HSP47 in a child with severe osteogenesis imperfecta leading to early demise. p.R222 is a highly conserved residue located within the collagen interacting surface of HSP47. Binding assays show a significantly reduced affinity of HSP47-R222S for type I collagen. This altered interaction leads to posttranslational overmodification of type I procollagen produced by dermal fibroblasts, with increased glycosylation and/or hydroxylation of lysine and proline residues as shown by mass spectrometry. Since we also observed a normal intracellular folding and secretion rate of type I procollagen, this overmodification cannot be explained by prolonged exposure of the procollagen molecules to the modifying hydroxyl- and glycosyltransferases, as is commonly observed in other types of OI. We found significant upregulation of several molecular chaperones and enzymes involved in procollagen modification and folding on Western blot and RT-qPCR. In addition, we showed that an imbalance in binding of HSP47-R222S to unfolded type I collagen chains in a gelatin sepharose pulldown assay results in increased binding of other chaperones and modifying enzymes. The elevated expression and binding of this molecular ensemble to type I procollagen suggests a compensatory mechanism for the aberrant binding of HSP47-R222S, eventually leading to overmodification of type I procollagen chains. Together, these results illustrate the importance of HSP47 for proper posttranslational modification and provide insights into the molecular pathomechanisms of the p.(R222S) alteration in HSP47, which leads to a severe OI phenotype.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33524049      PMCID: PMC7877763          DOI: 10.1371/journal.pgen.1009339

Source DB:  PubMed          Journal:  PLoS Genet        ISSN: 1553-7390            Impact factor:   5.917


  46 in total

1.  Accumulation of type IV collagen in dilated ER leads to apoptosis in Hsp47-knockout mouse embryos via induction of CHOP.

Authors:  Toshihiro Marutani; Akitsugu Yamamoto; Naoko Nagai; Hiroshi Kubota; Kazuhiro Nagata
Journal:  J Cell Sci       Date:  2004-11-02       Impact factor: 5.285

2.  Specific recognition of the collagen triple helix by chaperone HSP47: minimal structural requirement and spatial molecular orientation.

Authors:  Takaki Koide; Shinichi Asada; Yoshifumi Takahara; Yoshimi Nishikawa; Kazuhiro Nagata; Kouki Kitagawa
Journal:  J Biol Chem       Date:  2005-12-02       Impact factor: 5.157

3.  Autophagic elimination of misfolded procollagen aggregates in the endoplasmic reticulum as a means of cell protection.

Authors:  Yoshihito Ishida; Akitsugu Yamamoto; Akira Kitamura; Shireen R Lamandé; Tamotsu Yoshimori; John F Bateman; Hiroshi Kubota; Kazuhiro Nagata
Journal:  Mol Biol Cell       Date:  2009-04-08       Impact factor: 4.138

4.  Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta.

Authors:  Wayne A Cabral; Weizhong Chang; Aileen M Barnes; MaryAnn Weis; Melissa A Scott; Sergey Leikin; Elena Makareeva; Natalia V Kuznetsova; Kenneth N Rosenbaum; Cynthia J Tifft; Dorothy I Bulas; Chahira Kozma; Peter A Smith; David R Eyre; Joan C Marini
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

5.  Xaa-Arg-Gly triplets in the collagen triple helix are dominant binding sites for the molecular chaperone HSP47.

Authors:  Takaki Koide; Yoshifumi Takahara; Shinichi Asada; Kazuhiro Nagata
Journal:  J Biol Chem       Date:  2001-12-19       Impact factor: 5.157

Review 6.  Hsp47: a collagen-specific molecular chaperone.

Authors:  K Nagata
Journal:  Trends Biochem Sci       Date:  1996-01       Impact factor: 13.807

Review 7.  New perspectives on osteogenesis imperfecta.

Authors:  Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2011-06-14       Impact factor: 43.330

8.  Genetic analysis of osteogenesis imperfecta in the Palestinian population: molecular screening of 49 affected families.

Authors:  Osama Essawi; Sofie Symoens; Maha Fannana; Mohammad Darwish; Mohammad Farraj; Andy Willaert; Tamer Essawi; Bert Callewaert; Anne De Paepe; Fransiska Malfait; Paul J Coucke
Journal:  Mol Genet Genomic Med       Date:  2017-11-18       Impact factor: 2.183

9.  Novel compound heterozygous mutations in SERPINH1 cause rare autosomal recessive osteogenesis imperfecta type X.

Authors:  Y Song; D Zhao; X Xu; F Lv; L Li; Y Jiang; O Wang; W Xia; X Xing; M Li
Journal:  Osteoporos Int       Date:  2018-03-09       Impact factor: 4.507

10.  Mutants of collagen-specific molecular chaperone Hsp47 causing osteogenesis imperfecta are structurally unstable with weak binding affinity to collagen.

Authors:  Shinya Ito; Kazuhiro Nagata
Journal:  Biochem Biophys Res Commun       Date:  2015-12-12       Impact factor: 3.575

View more
  2 in total

1.  Lysyl hydroxylase 2 mediated collagen post-translational modifications and functional outcomes.

Authors:  Masahiko Terajima; Yuki Taga; Tomoyuki Nakamura; Hou-Fu Guo; Yukako Kayashima; Nobuyo Maeda-Smithies; Kshitij Parag-Sharma; Jeong Seon Kim; Antonio L Amelio; Kazunori Mizuno; Jonathan M Kurie; Mitsuo Yamauchi
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

Review 2.  Collagen transport and related pathways in Osteogenesis Imperfecta.

Authors:  Lauria Claeys; Silvia Storoni; Marelise Eekhoff; Mariet Elting; Lisanne Wisse; Gerard Pals; Nathalie Bravenboer; Alessandra Maugeri; Dimitra Micha
Journal:  Hum Genet       Date:  2021-06-24       Impact factor: 4.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.